表 2. Stage progression and pathological comparison of HAPE and COVID-19.
HAPE、COVID-19 各分期病情进展及病理表现
| 分期 | 病程分期/天 | 病理改变 | |||
| HAPE | COVID-19 | HAPE | COVID-19 | ||
| 早期 | 1 | 1~3 | 肺间质异常 | 肺间质异常 | |
| 进展期 | 2~3 | 3~7 | 肺实质病变 | ||
| 重症爆发期 | 4~5 | 7~14 | 肺实质病变 | ||
| 转归吸收期 | — | — | 肺间质异常 | ||
HAPE、COVID-19 各分期病情进展及病理表现
| 分期 | 病程分期/天 | 病理改变 | |||
| HAPE | COVID-19 | HAPE | COVID-19 | ||
| 早期 | 1 | 1~3 | 肺间质异常 | 肺间质异常 | |
| 进展期 | 2~3 | 3~7 | 肺实质病变 | ||
| 重症爆发期 | 4~5 | 7~14 | 肺实质病变 | ||
| 转归吸收期 | — | — | 肺间质异常 | ||